首页 | 本学科首页   官方微博 | 高级检索  
     

107例体外膜肺氧合并发症回顾分析
引用本文:高国栋,龙村,黑飞龙,刘晋萍,袁媛,于坤,冯正义,赵举,胡盛寿,许建屏,常谦,刘迎龙,张海涛,王旭,刘平. 107例体外膜肺氧合并发症回顾分析[J]. 心肺血管病杂志, 2010, 29(4): 296-300. DOI: 10.3969/j.issn.1007-5062.2010.04.010
作者姓名:高国栋  龙村  黑飞龙  刘晋萍  袁媛  于坤  冯正义  赵举  胡盛寿  许建屏  常谦  刘迎龙  张海涛  王旭  刘平
作者单位:1. 100037,北京中国医学科学院 北京协和医学院 阜外心血管病医院 体外循环科
2. 100037,北京中国医学科学院 北京协和医学院 阜外心血管病医院 心脏外科
3. 100037,北京中国医学科学院 北京协和医学院 阜外心血管病医院 外科ICU
基金项目:教育部博士点基金,院所青年科学基金 
摘    要:目的:总结阜外心血管病医院107例应用体外膜肺氧合(ECMO)支持治疗患者的并发症发生情况,探讨ECMO并发症的发生和防治,提高ECMO救治水平。方法:阜外医院2004年12月至2008年12月共对107例患者行ECMO支持治疗,回顾性分析总结其临床资料,探讨其并发症发生情况、原因、防治及并发症对ECMO结果的影响。结果:ECMO机械并发症主要有氧合器渗漏(28.4%)、氧合器置换(27.5%)及管路血栓(20.6%)等;机体并发症主要有出血和渗血(32.7%)、肾功能不全(28.3%)、溶血(14.0%)、感染(14例;13.1%)、神经系统并发症(11.2%)、肢体远端缺血(9例;8.4%)及多器官功能衰竭(6例;5.6%)等。肾衰、肢体缺血坏死、多器官功能衰竭(MSOR)及DIC等并发症影响患者预后。结论:ECMO并发症较多,危害较大,应尽量减少和避免并发症,对其积极治疗,进一步提高ECMO的救治水平。

关 键 词:体外膜肺氧合  心力衰竭  并发症

Retrospective analysis of complications of 107 patients managed by extracorporeal membrane oxygenation in fuwai hospital
GAO Guodong,LONG Cun,HEI Feilong,LIU Jinping,YUANG Yuan,YU Kun,FENG Zhengyi,ZHAO Ju,HU Shengshou,XU Jianping,CHANG Qian,LIU Yinglong,ZHANG Haitao,WANG Xu,LIU Ping. Retrospective analysis of complications of 107 patients managed by extracorporeal membrane oxygenation in fuwai hospital[J]. Journal of Cardiovascular and Pulmonary Diseases, 2010, 29(4): 296-300. DOI: 10.3969/j.issn.1007-5062.2010.04.010
Authors:GAO Guodong  LONG Cun  HEI Feilong  LIU Jinping  YUANG Yuan  YU Kun  FENG Zhengyi  ZHAO Ju  HU Shengshou  XU Jianping  CHANG Qian  LIU Yinglong  ZHANG Haitao  WANG Xu  LIU Ping
Affiliation:Department of Extra-Corporeal Circulation,CAMS ﹠ PUMC,Fuwai Hospital,Beijing 100037,China
Abstract:Objective: To retrospectively investigate and analyze the complications of 107 consecutive ECMO cases performed in Fuwai hospital from Dec. 2004 to Dec. 2008. Methods:107 patients with the ECMO supported in Fuwai hospital were studied for the incidence of complications. The inter-surface of the ECMO equipment system was completely coated by heparin-coating technique. All patients were applied veno-artery ECMO and activated clotting time (ACT) was maintained between 120-180 sec and heparin usage dose was 5-20 U/(kg·h). Mean blood flow was 40-220 mL/(kg·min) during ECMO assistant period. Results: We support 107 patients (age range 5days-76 years,median age (28. 86 ± 25. 20) years; weight range 3. 2-100 kg, median weight (43. 49 ± 29. 04) kg with extracorporeal membrane oxygenation. 68 patients (63. 6% ) weaned off successfully from ECMO. 62 of them were discharged and 6 died of post-operative complications. 45 patients could not weaned off from ECMO. Total survival discharge rate was 57. 9% . They suffered the complications, such as bleeding,renal failure,infection,neurological complications,lim ischemia MSOF and oxygenator plasma leakage with the incidence of 32. 7% ,28. 3% ,13. 1% ,11. 2% ,8. 4% ,5. 6% and 28. 4% respectively. renal failure,lim ischemia,MSOF,DIC are significantly related to nonsurvival rate. Conclusion: the complications increases the risk of ECMO support. Bleeding and oxygenator plasma leakage are the most important complications of ECMO. During the ECMO treatment,it is also important of prevent from the complications. Once they occur,active therapies must be carried out to save the patients lives.
Keywords:Extracorporeal membrane oxygenation  Heart failure  Complications
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号